24
Oct
2023

ABBVIE

Exhibitor at CPHI Barcelona 2023 stand 3E48, Contract Manufacturing and Services & stand E48, Meeting Room
About Us

AbbVie Contract Manufacturing has been serving as a trusted partner for more than 45 years across ten of our manufacturing facilities located in both North America and Europe. Our contract development and manufacturing capabilities span both small and large molecule API including classical fermentation, chemical synthesis, biologics and ADCs. In addition to APIs, we are offering extensive experience and technical solutions in drug product manufacturing which includes traditional tablet and capsule production, potent, hot melt extrusion, topical, eyecare and aseptic fill finish.  La...

  • US
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 3E48, Contract Manufacturing and Services

Products Featured at CPHI Barcelona 2023

  • Aseptic Fill Finish

    Product Aseptic Fill Finish

    We offer two convenient fill-finish options for parenteral drug products: prefilled syringe and vials. As a leading pharmaceutical partner, we can provide all necessary elements of delivering high-quality parenteral products for clinical and commercial needs.

    AbbVie will leverage its know...
  • Custom API

    Product Custom API

    AbbVie’s API site has the flexibility to run multiple chemical processes simultaneously to support late development phase to commercial products including highly potent drug containment up to OEL 3A (1 µg/m3). State of the art QC laboratories integrated across a highly experienced team focused on commercia...
  • Drug Product

    Product Drug Product

    Whether you’re developing a new chemical entity or a first-to-market generic, precise dosing and drug delivery is vital for success. Regulatory agencies and clinicians want to see well-characterized, reliable doses with good bioavailability. Patients/consumers often favor a controlled release dosage form, ...
  • Hot Melt Extrusion (HME)

    Product Hot Melt Extrusion (HME)

    Hot melt extrusion (HME) is a proven technology for bioavailability enhancement of poorly soluble API's. Unlike other formulation options, hot melt extrusion technology is solvent-free. By drawing on continuous processing, it is also more economical and can be used for abuse deference and taste masking app...
  • Fermentation

    Product Fermentation

    Fermentation is a critical step in both drug and toll manufacturing, as companies look to produce the core compounds that form their eventual products. While it is possible to undertake this in-house, the expertise contract fermentation services provide can improve the quality, affordability, speed and sca...